A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
A thief who tried to snatch £20 from a disabled teenage girl has been jailed after she fought him off and passers-by pinned him down.
The news that Jeremy Clarkson, Richard Hammond and James May are to present a new show on Amazon Prime has been met with a mixed response.
Authorities say Ai Weiwei failed to disclose a previous "criminal conviction" - though his supporters say he was never even charged.